Koninklijke Philips | PHG - Selling And Administration Expenses


Koninklijke Philips reported EUR1.52B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Demant DKK 6.09B 135M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Fresenius EUR 819M 143M Dec/2025
General Electric Aerospace USD 1.08B 496M Mar/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 318.48M 4.88M Dec/2025
GN Store Nord DKK 1.45B 41M Dec/2025
Hitachi JPY 491.37B 24.02B Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Koninklijke Philips EUR 1.52B 142.19M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Philips EUR 1.31B 127M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025